Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease

NCT00567177 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment of Dry Eye Disease

Interventions

DRUG: Restasis, Refresh Plus

Sponsor

Innovative Medical